Mon, May 27, 2024
Divi's Laboratories shares will gain traction in Monday's trade after the company came up with better Q4 numbers on the back of sharp surge in custom synthesis sales.
More >
Tue, Nov 08, 2022
According to ICICI Direct Research, the pharma major has reported in-line revenues with a significant miss on margins.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
